Gaucher Disease Trial, Recruiting NCT06151002 Sponsor: University College London Hospitals Condition: Gaucher Disease
Back to Gaucher Disease

Gaucher Disease Trial, Recruiting

NCT06151002
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been formally diagnosed with Parkinson's Disease by a doctor

Who may not be able to join:

  • You have been tested and found to carry a specific gene change called a GBA variant — if this applies to you, you may be directed to a related study called RAPSODI instead
  • You have been diagnosed with a condition similar to Parkinson's but with a different cause, such as progressive supranuclear palsy, multiple system atrophy, Parkinson's caused by a head injury, manganese poisoning, a past brain infection, problems with blood supply to the brain, or Parkinson's triggered by medication
  • You have another condition affecting the brain or nervous system, such as dementia, another movement disorder, or motor neurone disease
  • You are currently taking certain medications known to cause Parkinson's-like symptoms, including some antipsychotic or psychiatric drugs (such as Haloperidol, Olanzapine, or Risperidone), or other medicines including Bupropion, Lithium, Methyldopa, Metoclopramide, or Sodium Valproate (confirm with trial site if you are unsure whether your medication is included)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 020 801 68413

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University College London Hospitals
Registry
ClinicalTrials.gov
Start date
15 February 2020
Est. completion
14 February 2025

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Genotype of participants

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov